EFFECTS OF PROPAFENONE ON SINUS NODE FUNCTION IN THE RABBIT HEART

被引:1
作者
KERR, CR
机构
关键词
Atrium; Propafenone; Sinus node;
D O I
10.1139/y90-129
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Propafenone is a type 1C antiarrhythmic drug with efficacy for both ventricular and supraventricular arrhythmias. We investigated the effects of propafenone on properties of sinus node function in an in vitro preparation of rabbit sinus node and surrounding atrium. Spontaneous sinus cycle length (SCL), atriosinus conduction time (ASCT), and sinus node effective refractory period (SNERP) at multiple pacing cycling lengths were measured in the control state and during superfusion with propafenone (2.3 μM). SNERP prolonged from 175 ± 25 ms in the control state to 220 ± 45 ms (p < 0.001) with propafenone. ASCT also prolonged significantly (p < 0.01) from 50 ± 20 ms to 65 ± 20 ms whereas SCL did not change. In four experiments, multiple concentrations of propafenone were utilized and there appeared to be a dose-dependent prolongation of SNERP. Thus, propafenone has a significant effect on SNERP and ASCT in an isolated rabbit sinus node preparation.
引用
收藏
页码:851 / 855
页数:5
相关论文
共 31 条
[1]   LIDOCAINE, MEXILETINE AND PROPAFENONE IN THE TREATMENT OF ARRHYTHMIAS COMPLICATING MYOCARDIAL-INFARCTION - A CASE-REPORT [J].
AGUGLIA, F ;
GNECCHI, M ;
DEMARZIO, P .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1985, 7 (03) :303-306
[2]   PROPAFENON, A NEW ANTI-ARRHYTHMIC DRUG [J].
ALDOR, E ;
HEEGER, H .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1976, 101 (36) :1318-1322
[3]   LONG-TERM ORAL PROPAFENONE THERAPY FOR SUPPRESSION OF REFRACTORY SYMPTOMATIC ATRIAL-FIBRILLATION AND ATRIAL-FLUTTER [J].
ANTMAN, EM ;
BEAMER, AD ;
CANTILLON, C ;
MCGOWAN, N ;
GOLDMAN, L ;
FRIEDMAN, PL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 12 (04) :1005-1011
[4]  
BECK OA, 1975, MED KLIN, V70, P1713
[5]   COMBINED USE OF PROPAFEON AND LIDOFLAZINE IN CHRONIC ATRIAL-FIBRILLATION AND FLUTTER [J].
BECK, OA ;
HOCHREIN, H .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1980, 105 (36) :1243-1246
[6]   INDICATIONS AND RISKS OF ANTI-ARRHYTHMIA TREATMENT WITH PROPAFENONE [J].
BECK, OA ;
HOCHREIN, H .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1978, 103 (32) :1261-1265
[7]   RANDOMIZED PLACEBO-CONTROLLED TRIAL OF PROPAFENONE FOR TREATMENT OF ATRIAL TACHYARRHYTHMIAS AFTER CARDIAC-SURGERY [J].
CONNOLLY, SJ ;
MULJI, AS ;
HOFFERT, DL ;
DAVIS, C ;
SHRAGGE, BW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 10 (05) :1145-1148
[8]   CLINICAL-PHARMACOLOGY OF PROPAFENONE [J].
CONNOLLY, SJ ;
KATES, RE ;
LEBSACK, CS ;
HARRISON, DC ;
WINKLE, RA .
CIRCULATION, 1983, 68 (03) :589-596
[9]   ELECTROPHYSIOLOGICAL EFFECTS OF PROPAFENONE IN UNTREATED AND PROPAFENONE-PRETREATED GUINEA-PIG ATRIAL AND VENTRICULAR MUSCLE-FIBERS [J].
DELGADO, C ;
TAMARGO, J ;
TEJERINA, T .
BRITISH JOURNAL OF PHARMACOLOGY, 1985, 86 (04) :765-775
[10]  
DUKES ID, 1984, EUR J CARDIOL, V5, P15